The Resolute clinical trial program enrolled more than 5,000 patients worldwide, a third of whom had diabetes.
Here’s some good news for a change from the diabetes front: Lower-limb amputations due to diabetes complications dropped 65 percent from 1996 to 2008.
Novartis wrote to physicians world-wide then recommending that patients with Type 2 diabetes shouldn’t be treated with aliskiren, or combination products containing aliskiren, if they are also receiving an ACE inhibitor or ARB.
The prevention and treatment of diabetes-related blindness and cataract are the key topics on the agenda of the World Ophthalmology Congress 2012, which began on Thursday in Abu Dhabi.
Medicare paid $94 million for artificial feet in 2010, according to research conducted for The Associated Press. That was nearly $35 million more than in 2005, even though in 2010, Medicare covered about 1,900 fewer such prostheses.